Cal. Health and Safety Code § 124111
Cal. Health and Safety Code § 124111
California · California Health and Safety Code · Status: effective · Effective 2001-01-01
Cite this
- Citation
- Cal. Health and Safety Code § 124111, California, version 1 as recorded 2026-07-25, yourstate.us, https://yourstate.us/provision/875774
- Permanent ID
ys:prov:875774@1- SHA-256
ec9af2769180b077f30b57eeba623381f7dd09032bedd03ae6655b27c8e9d410
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) The Newborn Eye Pathology Screening Task Force is established and shall advise the State Department of Health Services on the newborn eye pathology screening protocol.
(b) The task force shall be composed of the following 12 members:
(1) The Director of Health Services as a nonvoting ex officio member.
(2) The 11 voting members shall be appointed by the Director of Health Services as follows:
(A) One ophthalmologist with a background in or knowledge of providing services to infants with retinoblastoma.
(B) One pediatric ophthalmologist who sees general pediatric patients and is a designee of the American Association for Pediatric Ophthalmology and Strabismus.
(C) One academic pediatrician with a background in or knowledge of infant eye pathology screening.
(D) One parent representing families with a child with blindness or other ocular abnormalities affecting vision.
(E) One representative from the California Academy of Family Physicians.
(F) One representative recommended by the State Department of Health Services.
(G) One representative from the American Academy of Pediatrics, California District.
(H) One community pediatrician with a background in or experience with the routine instillation of dilating eye drops as part of red reflex screening.
(I) One nurse with a background in or knowledge of the current department program for the instillation of eye drops to prevent conjunctivitis.
(J) One retinal specialist with research experience in detecting the signs of treatable congenital eye disease.
(K) One optometrist with a background in or experience with pupil dilation in infants and red reflex screening for intraocular pathology.
(c) Task force members shall serve without compensation, but shall be reimbursed for necessary travel expenses incurred in the performance of the duties of the task force.